companydata.dkcompanydata.dk

NORDIC BIOTECH HOLDING ApS: Financial statements 2024

CVR: 26409683

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

NORDIC BIOTECH HOLDING ApS (CVR 26409683) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -40,653 and a net result of DKK -39,278 compared with DKK -514,945 the year before. Equity in the 2024 report amounted to DKK 147,120. The solvency ratio was 29%.

Gross Profit
DKK -40,653
Profit/Loss
DKK -39,278
Equity
DKK 147,120
Total Assets
DKK 507,111
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--41K-39K147K0
2023--627K-515K578K-
2022-114K96K854K1
2021-325K305K758K1
2020-442K325K-462K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

NORDIC BIOTECH HOLDING ApS: The 2023 annual report is outJun 28, 2024

NORDIC BIOTECH HOLDING ApS has published its annual report for 2023. Gross profit came to DKK -626,579, and the net result was DKK -514,945.

About NORDIC BIOTECH HOLDING ApS

NORDIC BIOTECH HOLDING ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SN BIOTECH HOLDING ApS. The management consists of Torsten Bjørn. The company is owned by FINANSMANAGEMENT ApS. The company has 1 employee (2012). In 2025, the company reported a gross profit of DKK -39,555 and a net result of DKK -7,860 compared with DKK -39,278 the year before. Equity in the 2025 report amounted to DKK 139,260.

Source: annual report 2025, Danish Business Authority